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The Crystal Structure of the Reduced, Zn2-Bound
Form of the B. subtilis Hsp33 Chaperone
and Its Implications for the Activation Mechanism
conserved cysteines, Cys232, Cys234, Cys265, and
Cys268 (E. coli numbering). They are found in a Cys-
Xaa-Cys motif, followed by an approximately 30 residue
long fragment, and a Cys-(Xaa)2-Cys motif. This consti-
tutes a novel type of a Zn2 binding domain and is
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protein (Jakob et al., 2000). Under normal conditions,and Biological Physics
University of Virginia Zn2 is bound with very high affinity (Ka 1017 M1) by
the thiolate moieties of the four cysteines (Jakob et al.,Charlottesville, Virginia 22908
2 Synchrotron Radiation Research Section 2000). Oxidative stress results in the release of zinc
and the formation of two disulfides linking Cys232 withMacromolecular Crystallography Laboratory
NCI Cys234 and Cys265 with Cys268 (Barbirz et al., 2000),
leading to significant conformational changes and con-Brookhaven National Laboratory
Upton, New York 11973 comitant dimerization of the protein (Graumann et al.,
2001). Two recent independent crystallographic studies3 Department of Molecular, Cellular
and Developmental Biology revealed the structure of the larger, N-terminal domain
of the E. coli Hsp33, albeit in both cases the proteinUniversity of Michigan
Ann Arbor, Michigan 48109 was C terminally truncated, so that residues beyond
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Argonne National Laboratory were not observed (Kim et al., 2001; Vijayalakshmi et
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Building 202 dimer formed by a domain crossover, so that an all
helical fragment containing residues 179–218 from oneArgonne, Illinois 60439
monomer is packed onto the “back” of the N-terminal
/ type core of the other monomer. While both struc-
tures yielded significant insight into the overall Hsp33Summary
architecture and dimerization mode, neither shed light
on the mechanism of the activation switch leading toThe bacterial heat shock protein Hsp33 is a redox-
dimerization or on the mode of Zn2 binding. Recently,regulated chaperone activated by oxidative stress. In
biochemical and NMR studies suggested that under oxi-response to oxidation, four cysteines within a Zn2
dizing conditions the C-terminal Zn2 binding motif ofbinding C-terminal domain form two disulfide bonds
Hsp33 undergoes essentially complete unfolding fromwith concomitant release of the metal. This leads to
a highly compact and predominantly helical structurethe formation of the biologically active Hsp33 dimer.
(Graf et al., 2004). This oxidation-induced unfolding ofThe crystal structure of the N-terminal domain of the
Hsp33’s redox switch domain appears to be crucial forE. coli protein has been reported, but neither the struc-
the unmasking of the substrate binding site and dimer-ture of the Zn2 binding motif nor the nature of its
ization interface, raising the possibility that the folded,regulatory interaction with the rest of the protein are
reduced Zn2 binding domain may interfere with sub-known. Here we report the crystal structure of the
strate binding or dimerization. Once oxidized and dimer-full-length B. subtilis Hsp33 in the reduced form. The
ized, Hsp33 is highly active as a molecular chaperonestructure of the N-terminal, dimerization domain is
and protects unfolded proteins against irreversible ag-similar to that of the E. coli protein, although there is no
gregation (Graf and Jakob, 2002). Upon return to reduc-domain swapping. The Zn2 binding domain is clearly
ing nonstress conditions, a kinetically stable, reducedresolved showing the details of the tetrahedral coordi-
Hsp33 dimer surprisingly retains its high affinity for sub-nation of Zn2 by four thiolates. We propose a struc-
strate proteins. Release of the substrate proteins is trig-ture-based activation pathway for Hsp33.
gered by the DnaK/DnaJ/GrpE chaperone machinery,
which takes over the substrate proteins from the reduced
Introduction Hsp33 dimers and supports their refolding to the native
state. In the final step of the cycle, the substrate-free
Hsp33 is a novel bacterial molecular chaperone regu- reduced Hsp33 dimers dissociate slowly into the biologi-
lated by the redox conditions of the environment (Jakob cally inactive, monomeric state (Hoffmann et al., 2004).
et al., 1999). The E. coli Hsp33 gene, well conserved The full-length B. subtilis Hsp33 ortholog was origi-
and ubiquitous among prokaryotic organisms (Jakob et nally selected as one of the targets by the Midwest
al., 1999; Korber et al., 1999), is found in an operon Center for Structural Genomics (http://www.mcsg.anl.
immediately downstream of the one encoding the Hsp15 gov). However, the protein did not crystallize in the high-
heat shock protein. The amino acid sequence of the throughput pipeline. We have therefore used crystal en-
C-terminal domain of Hsp33 contains four absolutely gineering based on the concept of surface entropy re-
duction (Derewenda, 2004) to generate a crystallizable
variant. A double mutant of the full-length protein, in*Correspondence: zsd4n@virginia.edu
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Table 1. Data Collection and Refinement Statistics
Data Collection Statistics
Peak (1.2831 A˚) Inflection Point (  1.2837 A˚)
Space group and unit cell (A˚) P3121a  b  115.3 c  106.4
Resolution (A˚)a 50.0–1.97 (2.05–1.97) 30.0–1.97 (2.05–1.97)
Total reflections 460,699 543,743
Unique reflections 124,827 (12,464) 124,854 (12,466)
Redundancy 3.7 (3.7) 4.4 (4.3)
Completeness (%)a 100 (100) 100 (100)
Rsyma,b (%) 5.0 (51.2) 4.2 (35.2)
I/ (I)a,b 24.57 (2.64) 34.7 (4.1)
Phasing Statistics
Resolution (A˚) 50.0–2.50
Anomalous phasing power acentricc 0.34
Anomalous Rcullisd 0.81
Figure of merit 0.28
Refinement Statistics
Resolution (A˚) 20.0–1.97
Reflections (working) 56,615
Reflections (test) 1,186
Rwork (%)e 19.7
Rfree (%)e 22.4
Number of protein atoms 4,382
Number of waters 277
Number of acetate ions 6
Number of Zn ions 2
Rms deviations
Bond lengths (A˚) 0.025
Bond angles (	) 1.849
Average B factor (A˚2)
Main chain 36.0
Side chain 40.6
Waters 39.2
a Values in parentheses correspond to the last shell.
b Rsym  
|Ii  I|/
I, where Ii is the intensity of the i-th observation, and I is the mean intensity of the reflections. The values are for
unmerged Friedel pairs.
c Phasing power  rms (|Fh|/E), where |Fh| is the heavy atom structure factor amplitude, and E is residual lack of closure error.
d Rcullis  
||Fh.obs|  |Fh.calc||/
|Fh| for acentric reflections, where |Fh.obs| is the observed heavy atom structure factor amplitude, and |Fh.calc| is the
calculated heavy atom structure factor amplitude.
e Rwork  
||Fobs|  |Fcalc||/
|Fobs|, crystallographic R factor, and Rfree  
||Fobs|  |Fcalc||/
|Fobs|, where all reflections belong to a test set of
randomly selected data.
which alanines replaced the solvent-accessible Glu100 formation (Derewenda, 2004). Although this approach
implies a screening process using several mutants, inand Gln101, crystallized readily, and the resulting crys-
tals yielded diffraction to 2.0 A˚ resolution. The refined the case of the B. subtilis Hsp33 (BsHsp33), only one
mutant—in which residues Glu100 and Gln101 were re-crystal structure reveals a fully folded C-terminal Zn2
binding motif, with the metal ion coordinated tetrahe- placed with alanines—was sufficient to yield X-ray qual-
ity crystals. The structure was solved using anomalousdrally by the thiolate groups of Cys235, Cys237, Cys268,
and Cys271. Surprisingly, the N-terminal domains of two scattering from the Zn2 ions and was refined at 2.00 A˚
crystallographically independent molecules mediate the resolution to a conventional crystallographic R factor of
formation of a dimer closely reminiscent of the one ob- 19.7% and an Rfree of 22.5% (Table 1). The asymmetric
served for the E. coli protein, although no domain swap- unit contains a dimer of BsHsp33 molecules, one Zn2
ping is observed. We propose a general scheme for the ion bound per monomer, and a total of 6 acetate mole-
reversible activation of Hsp33, triggered by the forma- cules and 277 water molecules. Although the crystals
tion of intramolecular disulfides and sustained by the were soaked in 50 mM Zn acetate to ensure full Zn2
rate-limiting step of domain swapping. occupancy, subsequent experiments revealed that this
was not necessary (data not shown). The quaternary
structure of the dimer is equivalent to that described forResults and Discussion
the N-terminal fragment of the E. coli protein (EcHsp33)
(Kim et al., 2001; Vijayalakshmi et al., 2001). The packingStructure Solution and Quality of the Model
in the crystal lattice is such that monomer A mediatesGiven that the wild-type protein failed to crystallize, we
most crystal contacts, while monomer B is involved pri-applied the strategy of mutational surface entropy re-
duction to create patches conducive to crystal contact marily in intramolecular contacts. Consequently, mono-
Crystal Structure of the Reduced Full-Length Hsp33
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Figure 1. The Structure of Hsp33
(A) A ribbons representation of the B. subtilis Hsp33 noncrystallographic dimer. The two monomers are colored green and red, respectively.
Yellow and magenta denote linker regions corresponding to those responsible in the E. coli protein for the domain-swapping effect. The zinc
ions are shown as blue spheres. (B) The E. coli Hsp33 core domain, showing the architecture of domain swapping. The color code is the
same as in (A).
(C) Stereo view of the omit electron density map contoured at 2.5  corresponding to the linker regions. The ribbon diagram shows the
crossover as observed in the E. coli protein.
mer A has a lower mean main-chain temperature factor (Kim et al., 2001; Vijayalakshmi et al., 2001), folds back
onto its parent molecule (Figure 1C). The helical domain(32 A˚2) compared to monomer B (36 A˚2). There are 9
disordered residues in molecule A and 22 in molecule (H5–H7) shows considerable intrinsic flexibility, as in-
ferred from the conformational differences between theB. An analysis of the Ramachandran plot shows that
99.3% of the residues are in the most favored or allowed two molecules in the asymmetric unit. Among the most
dramatic differences, the Pro181-Gly182 peptide isregions.
flipped in molecule A compared to B, and the oligopep-
tide Asp184-Thr187 forms a  turn in one case while itThe B. subtilis and E. coli Hsp33 Proteins
is an integral part of the H5 helix in the other.Have Similar Core Domains
The 24% amino acid sequence identity shared by the
B. subtilis and E. coli proteins is consistent with a high Structure of the Zn2 Binding Domain
The C-terminal, Zn2 binding domain of the BsHsp33level of structural similarity between the dimerization
domains of the two proteins (Figures 1A and 1B). How- adopts a unique tertiary fold with a significant helical
content, as predicted by the CD and NMR spectroscopyever, the reduced form of the BsHsp33 shows no domain
swapping, which is well documented in the two reported (Graf et al., 2004). It consists of two short canonical
loops (Harding, 2004) containing Cys235-Xaa-Cys237structures of the EcHsp33 fragments (Kim et al., 2001;
Vijayalakshmi et al., 2001). Residues 181–187, equiva- and Cys268-(Xaa)2-Cys271, which are connected by a
31-residue-long oligopeptide. Following the terminallent to the extended linker connecting the two swapped
domains in the EcHsp33 structure (residues 178–184), 11 strand of the core domain (Vijayalakshmi et al.,
2001), the polypeptide enters the Zn2 binding domainshow well-resolved electron density in both molecule A
and B. They indicate how the fragment containing heli- in an extended conformation and then forms two short
helices (residues 239–250 and 251–263), an antiparallelces H5, H6, and H7, as defined in the EcHsp33 structures
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Figure 2. Sequence Homology of the C-Ter-
minal Domain of Hsp33
The C-terminal domain of Hsp33 has been
aligned using CLUSTALW. The zinc coordi-
nating cysteines are indicated with arrows.
The secondary structure of Bacillus protein
is shown below the alignment. GenBank ac-
cession numbers are indicated on the left.
Bs, Bacillus subtilis; Ec, Escherichia coli; Bd,
Bdellovibrio bacteriovorus; Li, Leptospira in-
terrogans; Yp, Yersinia pestis; Hi, Haemophi-
lus influenzae; Dr, Deinococcus radiodurans;
Cv, Chromobacterium violaceum; Sm, Strep-
tococcus mutans; Pa, Pseudomonas aerugi-
nosa; Vc, Vibrio cholerae; Tm, Thermotoga
maritim.
hairpin  structure (residues 263–269 and 271–278), and an H bond from the N1 of Arg86 (3.4 A˚), while Cys237,
which has no amide proton donors in its vicinity, acceptsa final  helix (residues 279–289) (Figure 1A). The tertiary
fold brings together the hairpin and the initial extended an H bond from the hydroxyl of Tyr275. Arg86 is highly
conserved (only two sequences show Lys in its place),stretch by means of the Zn2 binding site and a small
hydrophobic core of highly conserved Ile246, Ile254, while Tyr275 is the only absolutely conserved amino
acid in the Zn2 binding domain (except for the fourPhe277, Leu282, and Leu285 (Figure 2). The Zn2 ion is
coordinated in a tetrahedral fashion by the thiolates of cysteines) among the known Hsp33 homologs, sug-
gesting an important structural and functional role. Inter-the four conserved cysteines. Cys235 and Cys237 are
located at the N terminus of the domain, while Cys268 actions of arginines and tyrosines with thiolates are
known in other redox-regulated proteins. For example,and Cys271 are located at the hairpin apex between
two  strands (Figure 3). A comparison to other recently in the hydroperoxide resistance protein Ohr, the active
site cysteine Cys60, which is directly involved in thecataloged CCCC-type zinc binding proteins (Harding,
2004) revealed no structurally analogous examples, al- peroxide reduction, in a ground state accepts a hydro-
gen bond from N1 of Arg18, also at 3.4 A˚ (Lesniak et al.,though, taken individually, short cysteine-containing
loops are ubiquitous. The S-Zn2 distances in BsHsp33 2002). In the isoenzyme 3-3 of glutathione S-transferase,
the H bond between Tyr6 and the thiolate of the glutathi-range from 2.27 A˚ to 2.39 A˚, all within an experimental
error of the expected 2.31 A˚ for a thiolate-Zn2 bond one stabilizes the thiolate ion by 1.4–2.2 kcal/mol (Liu
et al., 1992). Overall, this intricate H-bonding network is(Simonson and Calimet, 2002). All four thiolates are in-
volved in a network of H bonds which constitute the likely to substantially reduce the pKa for the thiol groups,
thus rationalizing the observed high affinity of this motifouter coordination sphere, similar to that described for
the LIM2 domain of CRP2 (Konrat et al., 1998). Three of toward a Zn ion.
the thiolates (Cys235, Cys268, and Cys271) serve as
H-bond acceptors for the main chain amides of Cys237, Mutual Disposition of the Zn2 Binding
and Dimerization DomainsPhe270, and Glu273, respectively. The donor-acceptor
distances range between 3.5 A˚ and 3.7 A˚, well within The Zn2 binding domain forms a very limited interface
with the dimerization domain in BsHsp33, so that thethe expected range. In addition, Cys235 also accepts
Figure 3. Stereo View of Zn2 Coordination
The Zn2 ion of monomer A is shown with only the side chains of the four cysteines, Arg 86, and Tyr 275 shown. Hydrogen bonds are shown
as magenta lines; metal sulfur bonds are shown as black lines. Other details are in the main text.
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the chaperone activity. The two known crystal structures
of the dimerization domains of the EcHsp33, which lack
the presumably unfolded C-terminal domain, appear to
correspond to the biologically active Hsp33 species
(Kim et al., 2001; Vijayalakshmi et al., 2001), while the
C-terminal Zn2 binding domain of EcHsp33 (218–287)
does not have any chaperone activity (S. Van Haerents
and U.J., unpublished results). This indicates that the
substrate binding site of Hsp33 is located in the dimer-
ization domain. Upon reduction, the biologically active
dimer does not dissociate, but maintains biological ac-
tivity for some time (Hoffmann et al., 2004). These re-
duced, active Hsp33 dimers are further stabilized by
bound protein substrate, and no significant substrate
release or Hsp33 dissociation can be observed unless
the DnaK-system is present. Once the substrate is re-
leased, the reduced Hsp33 dimers dissociate slowly into
the inactive reduced Hsp33 monomers (Hoffmann et al.,
2004). Analysis of the dissociation kinetics of substrate-
free reduced Hsp33 dimers indicated that, when tested
in the physiologically relevant concentration range of
Hsp33 of 3–10 M, the dissociation is a concentration-
Figure 4. The Redox Regulation Cycle of Hsp33 independent process, consistent with an irreversible
(A) Upon exposure to oxidative stress, two disulfide bonds form in process (Hoffmann et al., 2004).
the monomeric species, and the C-terminal domain unfolds, releas- To rationalize this cycle in structural terms, it was
ing zinc (B). A high-affinity dimer is formed by domain swapping postulated that in the nascent, reduced Hsp33 mono-
(C). Subsequent reduction allows for the formation of a kinetically
mer, the Zn2-bound C terminus obscures the dimeriza-stable domain-swapped dimer that coordinates zinc and retains the
tion interface and/or the functional substrate bindingability to bind protein substrates (D). Once the substrate has been
released, the dimers can dissociate (E) and return to the monomeric surfaces of Hsp33 (Graf et al., 2004). Unexpectedly, our
form (A). crystal structure shows that the Zn2 binding domain
does not interfere with dimerization, and the protein
indeed forms a homodimer similar to that postulated for
only fragment of the Zn2 binding domain involved in the oxidized form. This would suggest that we have
this interface is the Cys-containing hairpin loop 269–271 solved the structure of the active, reduced dimeric
and, notably, the side chain of Phe270, which is seques- Hsp33 species. This, however, was somewhat surpris-
tered between Arg86 and Tyr88, stabilizing the relative ing, given that we were able to crystallize reduced Hsp33
orientation of the two domains. The orientation of the dimers without prior oxidation and dimerization. To as-
Zn2 binding domain is also locked by the conformation sess to what extent reduced BsHsp33 monomers can
of Arg86, protruding into the metal binding site from indeed associate in vitro, we attempted to determine
the dimerization domain. There is also an electrostatic the dissociation constant (KD) of the BsHsp33 dimer
cohesive interaction in the form of a salt bridge between using ultracentrifugation and fluorescence anisotropy.
Arg31 and Glu273. Overall, the total buried surface be- This proved difficult due to formation of higher oligomers
tween the dimerization domain and the Zn binding do- at high protein concentrations (100 M), but we were
main is approximately 1000 A˚2, a mere 7% of the total able to detect dimers of BsHsp22 down to 10 M con-
solvent-accessible surface of the monomeric BsHsp33. centration. This is in contrast to the reduced EcHsp33,
which is distinctly monomeric at these physiological
Molecular Mechanism of Redox concentrations (Graumann et al., 2001). This shows that
Regulation of Hsp33 the B. subtilis protein exhibits slightly different proper-
According to the current model, the Hsp33 proteins un- ties, explaining the presence of the homodimer in the
dergo profound structural reorganization as a result of crystals grown from a solution with a high protein con-
oxidation-induced loss of Zn2 and disulfide bond for- centration. However, upon dilution to physiologically rel-
mation (Graf et al., 2004). The same model implies the evant concentrations, the BsHsp33 dimers appear to
existence of several distinct forms of the protein. The quickly dissociate into the inactive monomeric species.
nascent form obtained under the reducing intracellular This was confirmed with in vitro chaperone assays using
conditions is monomeric and biologically inactive. Upon both thermally unfolded and chemically unfolded sub-
exposure to an oxidative stress, two disulfides, i.e., strate proteins (data not shown). We conclude that the
Cys235-Cys237 and Cys268-Cys271, are formed, with crystal structure of the BsHsp33 corresponds to the na-
concomitant loss of Zn2. Because the metal ion acts scent, reduced form of Hsp33, and that the dimeric state
as a zipper linking two halves of the C-terminal domain, observed in the crystal is induced by the high protein
its release causes the antiparallel  hairpin to separate concentration and may not be physiologically relevant.
from the rest of the domain, which looses its tertiary struc- What, then, are the pathways of structural changes
ture and unfolds. This will likely result in the loss of other that accompany the activation and deactivation of the
interdomain interactions, such as those involving Phe270. chaperone function in the Hsp33 family? Figure 4 illus-
trates a hypothetical scheme that is consistent with ourThe next step is the dimerization, a prerequisite for
Structure
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alanine. A number of successful applications of this
strategy have been reported to date (Janda et al., 2004;
Munshi et al., 2003; Prag et al., 2003), and the method
has the potential to become a routine tool. In the case
of the BsHsp33 structure, the mutated residues are
found on an external loop preceding helix H3 in the
dimerization domain. The crystal structure shows that,
in one of the monomers, this loop forms a direct contact
with a symmetry-related molecule (Figure 5), although
in monomer B it is not involved in crystal contacts. None-
theless, given that the wild-type protein would not crys-
tallize, the crystal contact mediated by molecule A was
clearly critical for crystallization. The mutation site is
distant from the putative functional surfaces and from
the Zn2 binding domain, and it is unlikely to have af-
fected the structure of BsHsp33.
Experimental Procedures
Protein Expression and Purification
The pMCSG7 expression vector containing the B. subtilis Hsp33
gene with an N-terminal His6 tag was obtained from the Midwest
Center for Structural Genomics. Expression was carried out in E. coliFigure 5. Crystal Contacts at Surface Mutagenesis Sites
BL21(DE3) strain in Luria-Bertani medium (LB). Wild-type and mu-The crystal contact mediated by the patch containing mutated sites
tant proteins were produced after induction with 1 mM IPTG at 20	C,Glu100→Ala, Gln101→Ala. A 2mFobs-DFcalc electron density map was
when OD600 reached 5.0. Cells were harvested by centrifugationcontoured at 1 . The symmetry-related molecule is shown in rib-
and lysed by sonication. The soluble fractions were isolated bybons representation; only selected side chains making contact with
centrifugation, and the tagged Hsp33 protein was bound to a Ni-the mutated loop are shown.
affinity column and subsequently eluted in an imidazole gradient
(50–100 mM). Following proteolysis with rTEV, the His6 tag was
removed together with tagged protease by Ni-affinity chromatogra-
structure as well as with other previous work. We sug- phy. Hsp33 was dialyzed against a buffer containing 20 mM Tris
(pH 8.0) and concentrated to 15 mg/ml (Bradford assay-BioRad).gest that the oxidation-induced unfolding of the Zn2
binding domain allows for the formation of a domain-
Design and Preparation of the Crystallizable Mutantswapped, oxidized Hsp33 dimer with a much lower KD,
A double mutant with a reduced surface entropy patch (Derewenda,due to a significantly larger buried intermolecular inter-
2004) was designed based on the existing crystal structures of theface. Strong experimental support for this mechanism
E. coli Hsp33 fragment (Kim et al., 2001; Vijayalakshmi et al., 2001).
comes from two independent crystallographic studies Two residues with high conformational entropy, Glu 100 and Gln
of the truncated EcHsp33 protein, both of which show 101, located on a solvent-exposed loop, were mutated to alanines.
The mutagenesis was performed with the QuikChange kit using adomain swapping (Kim et al., 2001; Vijayalakshmi et al.,
single primer. The mutant was expressed and purified in the same2001), suggesting that in the absence of the folded Zn2
way as the wild-type protein.binding domain, this is the thermodynamically preferred
species. Upon reduction and concomitant refolding of
Crystallization and Data Collectionthe Zn2 binding domain, a domain-swapped, biologi-
The screens using the wild-type and mutated protein were carried
cally active Zn2-bound dimer may form, as suggested out using 96 solutions, a subset of the 108 best crystallization condi-
by experimental studies (Hoffmann et al., 2004). How- tions reported by the Joint Center for Structural Genomics (Page et
al., 2003). No crystals for the wild-type protein were observed, whileever, the substrate-free reduced Hsp33 dimers are not
the mutated protein yielded diffraction-quality crystals straight fromthermodynamically stable but rather kinetically stable
the screen. The optimal conditions were 1.55 M K/Na tartrate, 0.1 Mand dissociate slowly at 25	C. Most likely, the rate-lim-
HEPES (pH 7.5). Because Hsp33 binds Zn2, the K/Na tartrate wasiting step in the dissociation process of reduced Hsp33
gradually exchanged for 2.0 M Li2SO4 in 0.1 M HEPES (pH 7.5), and
dimers is the formation of the nondomain-swapped crystals were flash frozen in the artificial mother liquor with the
Hsp33 dimer—whose structure we have solved—which addition of 20% glycerol solution as a cryoprotectant and 50 mM
Zn-acetate to ensure complete saturation of the Zn binding site.can readily dissociate.
Data were collected at B9X beamline at the National Synchrotron
Light Source (NSLS) at nominal wavelengths of 1.28310 A˚ (absorp-Crystal Contacts and the Surface
tion peak for Zn2) and 1.2837 A˚ (inflection point). The unit cell was
Entropy Reduction identified as P3121, a  b 115.3 A˚, c  106.4 A˚. The Matthews
As stated earlier, the preparation of the X-ray quality coefficient is 3.2 A˚3/Da, assuming two polypeptide chains per asym-
metric unit. Processing and merging of the data was carried outcrystals of the BsHsp33 protein was made possible by
with HKL2000 (Otwinowski and Minor, 1997). Further details arethe application of the recently proposed surface entropy
given in Table 1.reduction approach (Derewenda, 2004; Garrard et al.,
2001; Longenecker et al., 2001). The method relies on
Structure Solution and Refinementthe concept that crystal-forming surface patches can
The anomalous substructure of two Zn2 atoms was solved with
be engineered by replacing residues with high confor- SHELXD (Schneider & Sheldrick, 2002), and phases were calculated
mational entropy (e.g., lysines, glutamates, glutamines, with data for both wavelengths using MLPHARE from the CCP4
suite (CCP4, 1994). Part of the model was built automatically in ARP/etc.) with residues with little or no entropy, such as
Crystal Structure of the Reduced Full-Length Hsp33
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wARP (Perrakis et al., 1999), which built 475 out of 582 residues Konrat, R., Weiskirchen, R., Bister, K., and Krautler, K. (1998). Bispheric
coordinative structuring in a zinc finger protein: NMR analysis of aexpected for two full-length Hsp33 molecules in the asymmetric
unit. The program O (Jones et al., 1991) was used for subsequent point mutant of teh carboxy-terminal LIM domain of quail cysteine-
and glycine-rich protein CRP2. J. Am. Chem. Soc. 120, 7127–7128.map interpretation and manual model building. The model was re-
fined with REFMAC5 (Murshudov et al., 1997) against data collected Korber, P., Zander, T., Herschlag, D., and Bardwell, J.C. (1999). A
at the absorption peak wavelength, with all reflections to 1.97 A˚ new heat shock protein that binds nucleic acids. J. Biol. Chem. 274,
resolution. Individual isotropic displacement parameters (B factors) 249–256.
were used throughout. The validation of the model was carried out Laskowski, R.A., McArthur, M.W., Moss, D.S., and Thornton, J.M.
using MOLPROBITY (Lovell et al., 2003) and PROCHECK (Laskowski (1993). PROCHECK: a program to check the stereochemical quality
et al., 1993). Further details are given in Table 1. of protein structures. J. Appl. Crystallogr. 26, 282–291.
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